COM:CELYAD
Celyad Oncology
- Stock
Last Close
0.55
31/03 15:35
Market Cap
11.14M
Beta: -
Volume Today
13.66K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 456.50K - | 456.50K 0% | 781.50K - | 781.50K 0% | 0.50 - | ||||||
average payables | 3.11M - | 6.31M 103.14% | 8.34M 32.14% | 6.45M 22.65% | 5.36M 16.92% | 6.44M 20.24% | 5.85M 9.16% | 5.67M 3.06% | 5.68M 0.14% | 3.00M 47.24% | |
average receivables | 1.07M - | 1.19M 10.84% | 1.01M 15.11% | 796K 20.87% | 300K 62.31% | 1.53M 411.50% | 1.80M 17.60% | 1.62M 10.03% | 1.80M 10.84% | 1.99M 10.42% | |
book value per share | 3.95 - | 13.13 232.23% | 9.74 25.83% | 4.94 49.29% | 4.99 1.04% | 3.64 27.01% | 2.22 38.97% | 2.80 25.80% | 0.19 93.17% | ||
capex per share | -0.09 - | -0.10 4.13% | -0.19 93.45% | -0.09 53.32% | -0.16 77.73% | -0.05 68.65% | -0.02 53.93% | -0.03 10.08% | -0.01 78.38% | ||
capex to depreciation | -0.74 - | -0.81 10.28% | -1.18 44.90% | -0.10 91.89% | -1.58 1,562.68% | -0.35 78.04% | -0.17 49.95% | -0.26 48.49% | -0.09 66.96% | ||
capex to operating cash flow | 0.04 - | 0.03 16.49% | 0.07 135.14% | 0.02 76.01% | 0.06 274.05% | 0.02 65.95% | 0.01 47.72% | 0.01 27.92% | 0.00 70.23% | ||
capex to revenue | -4.38 - | -279.33 6,272.29% | -0.21 99.93% | -0.24 15.92% | -0.57 133.78% | -103.67 18,195.85% | -63.80 38.46% | ||||
cash per share | 4.49 - | 12.67 182.15% | 8.85 30.12% | 3.52 60.20% | 4.47 26.74% | 3.14 29.65% | 1.24 60.65% | 1.92 55.63% | 0.55 71.37% | ||
days of inventory on hand | 2.90K - | ||||||||||
days payables outstanding | 12.83K - | 490.48 96.18% | 55.77K 11,270.35% | 3.40K 93.90% | 6.58K - | ||||||
days sales outstanding | 4.29K - | 79.45K 1,750.86% | 58.20 99.93% | 24.02 58.72% | 43.00 79.00% | 164.37K 382,131.15% | 66.21K 59.72% | 9.72K - | |||
debt to assets | 0.01 - | 0.00 54.95% | 0.01 151.65% | 0.02 74.70% | 0.02 6.17% | 0.05 178.24% | 0.06 13.35% | 0.03 40.19% | 0.01 60.72% | 0.01 25.92% | |
debt to equity | 0.02 - | 0.01 60.88% | 0.02 168.57% | 0.03 86.80% | 0.03 2.53% | 0.10 223.01% | 0.12 22.73% | 0.06 48.62% | 0.06 2.06% | 0.02 58.11% | |
dividend yield | |||||||||||
earnings yield | -0.07 - | -0.07 2.12% | -0.14 101.86% | -0.17 19.64% | -0.20 15.62% | -0.24 19.95% | -0.19 19.55% | -0.48 154.92% | -3.58 640.75% | ||
enterprise value | 201.62M - | 314.21M 55.84% | 119.30M 62.03% | 310.02M 159.87% | 145.90M 52.94% | 86.50M 40.71% | 78.70M 9.01% | 27.46M 65.11% | -757.46K 102.76% | -5.95M 684.99% | |
enterprise value over ebitda | -11.17 - | -11.28 0.99% | -5.45 51.70% | -18.60 241.33% | -3.90 79.01% | -3.15 19.30% | -3.25 3.24% | -1.07 67.00% | 0.04 103.75% | 0.56 1,293.46% | |
ev to operating cash flow | -11.58 - | -11.51 0.60% | -4.83 58.02% | -6.26 29.51% | -5.35 14.43% | -3.07 42.72% | -2.84 7.25% | -1.03 63.77% | 0.03 102.62% | ||
ev to sales | 1.38K - | 104.74K 7,484.36% | 14.00 99.99% | 87.58 525.67% | 46.84 46.52% | 14.42K 30,679.87% | 15.74K 9.18% | -58.29 - | |||
free cash flow per share | -2.67 - | -3.32 23.96% | -2.84 14.42% | -5.24 84.60% | -2.60 50.27% | -2.30 11.64% | -2.01 12.80% | -1.73 13.68% | -1.25 28.13% | ||
free cash flow yield | -0.08 - | -0.07 13.78% | -0.16 134.21% | -0.15 4.65% | -0.16 3.36% | -0.24 51.13% | -0.30 27.78% | -0.49 62.58% | -2.46 399.22% | ||
graham net net | 2.19 - | 7.06 223.10% | 3.82 45.85% | 0.41 89.16% | 1.01 144.79% | -0.23 122.44% | -1.18 416.23% | -0.29 75.31% | -0.09 69.37% | ||
graham number | 14.72 - | 31.84 116.23% | 23.55 26.04% | 25.52 8.38% | 19.13 25.03% | 13.69 28.45% | 7.92 42.12% | 10.34 30.49% | 2.79 73.01% | ||
income quality | 1.06 - | 0.94 11.40% | 1.05 11.54% | 1.15 9.86% | 0.73 36.64% | 0.98 35.29% | 1.61 63.26% | 1.00 37.51% | 0.68 31.91% | ||
intangibles to total assets | 0.23 - | 0.31 31.01% | 0.36 16.76% | 0.47 31.70% | 0.38 18.46% | 0.40 5.07% | 0.55 35.84% | 0.45 17.34% | 0.04 90.31% | 0 100% | |
interest coverage | -747.14 - | -125.73 83.17% | -123.71 1.60% | -11.87 90.40% | -615.65 5,085.88% | -85.64 86.09% | -88.35 3.17% | -103.49 17.15% | -207.40 100.39% | -126.15 39.17% | |
interest debt per share | 0.06 - | 0.11 66.55% | 0.18 68.26% | 0.61 239.36% | 0.15 74.98% | 0.38 145.07% | 0.28 24.89% | 0.19 34.45% | 0.02 89.19% | ||
inventory turnover | 0.13 - | ||||||||||
invested capital | 0.02 - | 0.01 60.88% | 0.02 168.57% | 0.03 86.80% | 0.03 2.53% | 0.10 223.01% | 0.12 22.73% | 0.06 48.62% | 0.06 2.06% | 0.02 58.11% | |
market cap | 228.84M - | 413.71M 80.79% | 166.18M 59.83% | 331.83M 99.68% | 184.80M 44.31% | 121.47M 34.27% | 92.30M 24.02% | 54.85M 40.58% | 11.43M 79.16% | ||
net current asset value | 15.64M - | 61.37M 292.30% | 37.45M 38.98% | 6.30M 83.17% | 12.98M 105.97% | -1.38M 110.64% | -15.38M 1,014.05% | -2.01M 86.92% | -574K 71.47% | 1.14M 299.13% | |
net debt to ebitda | 1.51 - | 3.57 136.88% | 2.14 40.07% | 1.31 38.89% | 1.04 20.46% | 1.27 22.40% | 0.56 55.89% | 1.07 90.51% | 0.65 39.48% | 0.56 13.41% | |
net income per share | -2.44 - | -3.43 40.73% | -2.53 26.24% | -5.86 131.62% | -3.26 44.37% | -2.29 29.87% | -1.26 45.10% | -1.70 35.36% | -1.81 6.63% | ||
operating cash flow per share | -2.58 - | -3.22 24.69% | -2.65 17.73% | -5.15 94.55% | -2.45 52.49% | -2.25 7.94% | -1.98 11.89% | -1.71 13.95% | -1.24 27.39% | ||
payables turnover | 0.03 - | 0.74 2,515.59% | 0.01 99.12% | 0.11 1,539.34% | 0.06 - | ||||||
receivables turnover | 0.09 - | 0.00 94.60% | 6.27 136,410.15% | 15.19 142.26% | 8.49 44.13% | 0.00 99.97% | 0.01 148.25% | 0.04 - | |||
research and ddevelopement to revenue | 108.66 - | 1.97K 1,709.55% | 3.25 99.83% | 6.47 99.29% | 7.57 16.96% | 4.21K 55,460.98% | 4.32K 2.68% | 45.12 - | |||
return on tangible assets | -0.49 - | -0.26 46.13% | -0.26 0.61% | -1.37 418.49% | -0.62 54.46% | -0.53 14.54% | -0.59 9.60% | -0.61 3.52% | -2.17 258.53% | -0.52 76.10% | |
revenue per share | 0.02 - | 0.00 98.37% | 0.91 258,350.35% | 0.37 59.73% | 0.28 23.98% | 0.00 99.83% | 0.00 25.15% | ||||
roe | -0.62 - | -0.26 57.64% | -0.26 0.55% | -1.19 356.76% | -0.65 44.94% | -0.63 3.92% | -0.56 10.03% | -0.61 7.59% | -9.48 1,460.79% | -1.34 85.87% | |
roic | -0.51 - | -0.26 48.26% | -0.28 4.77% | -1.06 285.40% | -0.63 40.14% | -0.54 14.47% | -0.70 28.66% | -0.54 22.67% | -8.48 1,470.35% | -1.43 83.15% | |
sales general and administrative to revenue | 34.36 - | 2.41K 6,914.75% | 1.14 99.95% | 2.63 130.04% | 3.33 26.79% | 1.45K 43,509.60% | 1.80K 23.71% | ||||
shareholders equity per share | 3.95 - | 13.13 232.23% | 9.74 25.83% | 4.94 49.29% | 4.99 1.04% | 3.64 27.01% | 2.22 38.97% | 2.80 25.80% | 0.19 93.17% | ||
stock based compensation to revenue | 7.52 - | 265 3,423.68% | 0.33 99.87% | 0.73 117.25% | 1.15 59.03% | 462.50 39,974.76% | 556.40 20.30% | ||||
tangible asset value | 16.42M - | 62.68M 281.80% | 41.32M 34.09% | 11.03M 73.31% | 19.43M 76.16% | 9.42M 51.51% | -5.18M 154.96% | 7.47M 244.31% | 3.45M 53.78% | 6.30M 82.57% | |
tangible book value per share | 2.43 - | 7.38 203.64% | 4.43 40.04% | 1.15 74.13% | 1.74 52.20% | 0.75 56.87% | -0.37 149.36% | 0.48 228.94% | 0.15 68.08% | ||
working capital | 26.88M - | 97.93M 264.29% | 74.09M 24.34% | 28.45M 61.60% | 42.05M 47.79% | 30.91M 26.47% | 7.87M 74.54% | 20.46M 160.01% | 4.40M 78.50% | 8.19M 86.16% |
All numbers in EUR (except ratios and percentages)